TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone
Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone
Sponsor: University of Utah
Terminated
Poor enrollment.
Other terminated trials from University of Utah
Other Myofascial Pain trials with similar outcome
A PHASE4 clinical study on Myofascial Pain, this trial is terminated or withdrawn. The trial is conducted by University of Utah and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 4 earlier versions
-
Mar 2020 — Dec 2020 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jun 2018 — Mar 2020 [monthly]
Recruiting PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .